|
AP2B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.546200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.125200E-01 |
| Normal-vs-Stage2 |
8.015000E-01 |
| Normal-vs-Stage3 |
6.793700E-02 |
| Normal-vs-Stage4 |
1.893770E-01 |
| Stage1-vs-Stage2 |
2.181400E-01 |
| Stage1-vs-Stage3 |
2.868600E-01 |
| Stage1-vs-Stage4 |
6.481200E-01 |
| Stage2-vs-Stage3 |
5.193900E-02 |
| Stage2-vs-Stage4 |
1.595010E-01 |
| Stage3-vs-Stage4 |
7.749600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.554610E-01 |
| Normal-vs-AfricanAmerican |
3.380000E-01 |
| Normal-vs-Asian |
9.429000E-01 |
| Caucasian-vs-AfricanAmerican |
4.001800E-02 |
| Caucasian-vs-Asian |
1.646000E-01 |
| AfricanAmerican-vs-Asian |
4.584600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.425500E-02 |
| Normal-vs-Female |
4.113400E-01 |
| Male-vs-Female |
1.542750E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.480600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.363000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.396640E-01 |
| Normal-vs-Age(81-100Yrs) |
2.135200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.555200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.228600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.027800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.091600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.201800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.809200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.345500E-02 |
| Classical-VS-Follicular |
2.182900E-03 |
| Classical-VS-Other |
3.886500E-02 |
| Classical-VS-Normal |
8.938200E-01 |
| Tall-VS-Follicular |
7.592600E-01 |
| Tall-VS-Other |
2.030400E-01 |
| Tall-VS-Normal |
1.045160E-01 |
| Follicular-VS-Other |
3.352000E-01 |
| Follicular-VS-Normal |
2.616200E-02 |
| Other-VS-Normal |
3.231900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.359400E-01 |
| Normal-vs-N1 |
1.703720E-02 |
| N0-vs-N1 |
8.843800E-02 |
|
|
